4.5 out of 5 stars
(55 Ratings)
StackAI is an enterprise AI automation platform built to help organizations create end-to-end internal tools and processes with AI agents. Unlike point solutions or one-off chatbots, StackAI provides a single platform where enterprises can design, deploy, and govern AI workflows in a secure, compliant, and fully controlled environment.
Using its visual workflow builder, teams can map entire processes — from data intake and enrichment to decision-making, reporting, and audit trails. Enterprise knowledge bases such as SharePoint, Confluence, Notion, Google Drive, and internal databases can be connected directly, with features for version control, citations, and permissioning to keep information reliable and protected.
AI agents can be deployed in multiple ways: as a chat assistant embedded in daily workflows, an advanced form for structured document-heavy tasks, or an API endpoint connected into existing tools. StackAI integrates natively with Slack, Teams, Salesforce, HubSpot, ServiceNow, Airtable, and more.
Security and compliance are embedded at every layer. The platform supports SSO (Okta, Azure AD, Google), role-based access control, audit logs, data residency, and PII masking. Enterprises can monitor usage, apply cost controls, and test workflows with guardrails and evaluations before production.
StackAI also offers flexible model routing, enabling teams to choose between OpenAI, Anthropic, Google, or local LLMs, with advanced settings to fine-tune parameters and ensure consistent, accurate outputs.
A growing template library speeds deployment with pre-built solutions for Contract Analysis, Support Desk Automation, RFP Response, Investment Memo Generation, and InfoSec Questionnaires.
By replacing fragmented processes with secure, AI-driven workflows, StackAI helps enterprises cut manual work, accelerate decision-making, and empower non-technical teams to build automation that scales across the organization.
Learn more about StackAI
4.6 out of 5 stars
(153 Ratings)
QBench is a cloud LIMS that gives testing laboratories one platform for samples, workflows, data, inventory, reporting, quality processes, and client interactions.
Every stage of lab operations runs through QBench, from order placement and sample processing to results and automated reporting. Because the platform is highly configurable, labs set up their own workflows, custom data fields, and automations to match how they already work, then adjust those settings as processes change without leaning heavily on custom code.
File parsers and a robust API link QBench with instruments, software, and other systems. Data moves between them automatically, which cuts down on repetitive entry and transcription errors. For deeper reporting, labs can connect QBench to Tableau, Power BI, Domo, and Looker via REST API.
Core features:
Sample and workflow tracking
Configurable workflows and custom fields
Automation
Instrument and system integrations
File parsers and API access
Inventory management
Client portal
Automated reporting
Analytics and operational insights
Tableau, Power BI, Domo, and Looker connectivity
Built-in Quality Management System (QMS)
Rather than requiring extensive custom development to fit a lab’s processes, QBench is designed to adapt, so changes to fields, processes, and automations stay in the lab’s hands.
Running in the cloud, QBench keeps lab data, workflows, quality management, and reporting secure and centralized. Former bench scientists on the QBench team help customers through implementation and ongoing use.
Learn more about QBench
The Galen Platform
Ibex Medical Analytics leads the way in the application of AI technology for cancer diagnostics within pathology. Our multidisciplinary team consists of entrepreneurs, software engineers, data scientists, and healthcare professionals who share a common goal: to transform cancer diagnostics through artificial intelligence, ultimately improving the quality of patient care. As the number of tests conducted each year increases, pathologists encounter considerable challenges in providing accurate and timely evaluations. To tackle these issues, Ibex utilizes AI to develop clinical-grade solutions designed to detect cancer with a level of precision comparable to that of human pathologists. The Galen Platform uses sophisticated algorithms to analyze imaging, identify and categorize cancer in biopsy samples, and emphasize other clinically relevant findings, which aids pathologists in reducing diagnostic mistakes and enhancing their workflow efficiency. In particular, Ibex's Galen™ Prostate and Galen™ Breast tools are groundbreaking AI-driven cancer detection solutions that have been integrated into standard clinical practice in pathology laboratories, demonstrating proven effectiveness in identifying cancer cases that were previously overlooked. As we persist in our quest for progress, our dedication to advancing cancer detection and improving patient outcomes continues to be resolute and inspiring for the entire medical community.
Learn more about The Galen Platform
Qritive
Improving the speed, accuracy, and cost-effectiveness of cancer diagnoses is essential, given that one in three people are likely to confront this illness in their lives. The existing diagnostic methods, however, are often slow and expensive, primarily due to a shortage of sophisticated automated tools that can aid healthcare providers. Qritive seeks to overcome this issue by providing an AI-powered solution that assists doctors in efficiently analyzing microscopy images alongside patient data. This breakthrough not only improves the diagnostic capabilities of hospitals but also results in substantial savings in healthcare costs. Furthermore, Pantheon acts as a CE-marked, vendor-neutral digital pathology platform that streamlines the entire digitization process for pathology laboratory workflows and telepathology services. It also enables thorough report generation and offers a powerful environment for AI-based analysis of whole-slide images in pathology. This innovative technology excels at differentiating between various benign conditions and malignant diseases in breast tissue, which is crucial for ensuring timely and precise treatment. By doing so, it significantly contributes to the evolution of cancer diagnostics and enhances patient outcomes in the long run.
Learn more about Qritive